Risk of Malignancy Index in the Evaluation of Patients With Adnexal Masses

Journal of Obstetrics and Gynaecology Canada

Volumn 31, Issue 5, 2009, Pages 440-445

  Clarke, Sharon E ^a   Grimshaw, Robert ^a   Rittenberg, Paula ^a   Kieser, Katharina ^a   Bentley, James ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adnexal mass; CA 125; Ovarian cancer; Risk of malignancy; Ultrasound

Indexed keywords

CA 125 ANTIGEN;

ADNEXA DISEASE; ADNEXA MASS; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSE; POSTMENOPAUSE; PREDICTION; PREDICTIVE VALUE; PREMENOPAUSE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ADOLESCENT; AGED; FEMALE GENITAL TRACT TUMOR; MIDDLE AGED; PREDICTION AND FORECASTING; RISK ASSESSMENT;

ADNEXAL DISEASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 70249114843     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34175-5     Document Type: Article

References (15)

1. Giede K.C., Kieser K., Dodge J., Rosen B. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol 2005, 99(2):447-461.
2. ACOG Committee Opinion The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Gynecol Oncol 2002, 100:1413-1416.
3. Gillis C.R., Hole D.J., Still R.M., Davis J., Kave S.B. Medical audit, cancer registration, and survival in ovarian cancer. Lancet 1991, 337:611-612.
4. Jacobs I., Oram D., Fairbanks J., Turner J., Frost C., Grudzinskas J.G. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990, 97:922-929.
5. Davies A.P., Jacobs I., Woolas R., Fish A., Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993, 100:927-931.
6. Morgante G., la Marca A., Ditto A., De Leo V. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynaecol 1999, 106:524-527.
7. Manjunath A.P., Pratapkumar Sujatha K., Vani R. Comparison of three risk of malignancy indices in evaluation of pelvic masses. Gynecol Oncol 2001, 81:225-229.
8. Bailey J., Tailor A., Naik R., Lopes A., Godfrey K., Hatem H.M., et al. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?. Int J Gynecol Cancer 2006, 16:30-34.
9. Tingulstad S., Hagen B., Skjeldestad F.E., Onsrud M., Kiserud T., Halvorsen T., et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 1996, 103(8):826-831.
10. Andersen E.S., Knudsen A., Rix P., Johansen B. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol 2003, 90:109-112.
11. Tingulstad S., Hagen B., Skjeldestad F.E., Halvorsen T., Nustad K., Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 1999, 94:448-452.
12. Sibley PE. BR-MA, GI-MA and OM-MA: Immunoassays for the tumor markers CA15-3, CA19-9, and CA125. Diagnostic Products Corporation Limited.
13. Aslam N., Tailor A., Lawton F., Carr J., Savvas M., Jurkovic D. Prospective evaluation of three different models for the pre-operative diagnosis of ovarian cancer. BJOG 2000, 107:1347-1353.
14. Mol B.W., Boll D., De Kanter M., Heintz A.P., Sijmons E.A., Oei S.G., et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol 2001, 80:162-167.
15. Van Calster B., Timmerman D., Bourne T., Testa A.C., Van Holsbeke C., Domali E., et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst 2007, 99:1706-1714.